Palabras claves: E2-classical swine fever virus, Formulation stability, Mammary gland expression, Recombinant veterinary vaccine
Autores: Aguero F., Aguilera A., Castell S., Farnos O., Figueredo J.M., Fonseca-Rodríguez O., Frias M.T., Maritza Barrera, Montesino R., Naranjo P., Prieto Y., Rodriguez M.P., Sanchez O., Toledo J.R.